Inactive Instrument

Insiders Lion Biotechnologies Inc OTC Bulletin Board

Equities

LBIO

US53619R1023

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

01/06	Transcript : Iovance Biotherapeutics, Inc. - Special Call
13/05	Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

General (Ret.) Merrill A. McPeak, Member of the Board of Directors of Iovance Biotherapeutics, Inc. Retires and Not Stands for Re-Election	30/03	CI
Iovance Biotherapeutics Insider Bought Shares Worth $45,750,000, According to a Recent SEC Filing	21/02	MT
Iovance Biotherapeutics Insider Bought Shares Worth $292,800, According to a Recent SEC Filing	21/02	MT
Iovance Biotherapeutics Insider Bought Shares Worth $2,287,500, According to a Recent SEC Filing	21/02	MT
Iovance Biotherapeutics Insider Bought Shares Worth $26,500,000, According to a Recent SEC Filing	18/23/18	MT
Iovance Biotherapeutics, Inc. Announces Wendy Dixon, Member of Board of Directors, Will Not Stand for Re-Election	27/23/27	CI
Iovance Biotherapeutics, Inc. Appoints Wendy L. Yarno as Director and New Member of the Board	25/23/25	CI
TScan Therapeutics Names Debora Barton as Chief Medical Officer	07/22/07	MT
Iovance Biotherapeutics, Inc. Appoints Wendy L. Dixon to Board of Directors	14/22/14	CI
Iovance Biotherapeutics Announces Raj K. Puri as Executive Vice President, Regulatory Strategy and Translational Medicine	10/22/10	CI
Alpine Immune Sciences : Appoints Chief Medical Officer	03/21/03	MT
Iovance Biotherapeutics, Inc. Announces Management Changes	19/21/19	CI
Iovance Biotherapeutics, Inc. Appoints Igor Bilinsky as Chief Operating Officer	16/21/16	CI
Iovance Biotherapeutics, Inc. Announces Board Changes	12/21/12	CI
Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer	14/20/14	CI
Iovance Biotherapeutics, Inc. Announces Executive Changes	13/20/13	CI
Iovance Biotherapeutics Appoints Friedrich Graf Finckenstein as Chief Medical Officer	18/19/18	CI
Iovance Biotherapeutics, Inc. Appoints Athena Countouriotis to its Board of Directors and Member of the Board’s Nominating and Corporate Governance Committee and the Compensation Committee	11/19/11	CI
Sanford J. Hillsberg Intends Not to Stand for Re-Election as Member of the Board of Directors of Iovance Biotherapeutics, Inc	15/18/15	CI
Iovance Biotherapeutics Announces Board Changes	01/18/01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Lion Biotechnologies Inc OTC Bulletin Board

Equities

LBIO

US53619R1023

Insiders

Filters